Sarcosine Distinguishes Prostate Cancer From BPH Sarcosine Distinguishes Prostate Cancer From BPH
This study assessed the diagnostic performance of plasma sarcosine as a complementary biomarker to PSA. How well does it distinguish malignancy from benign prostatic hyperplasia?Laboratory Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Health | Laboratory Medicine | Pathology | Prostate Cancer | Study